China Pharma Holdings (CPHI): Bathi resik saben saham sajrone 12 wulan pungkasan

The rolling annual earnings per share value for China Pharma Holdings (CPHI) demonstrates how the automation of tablet molding and packaging lines minimizes manual labor. Revenues are based on the supply of affordable generics to clinics and pharmacies in China. In its maturity stage, the company is optimizing production costs for dietary supplements. Consequently, -0.42 becomes the new metric value determining the business's actual ability to generate equity income.
Rincian analitis lan laporan data perusahaan China Pharma (CPHI)

China Pharma Holdings (CPHI) is optimizing costs by outsourcing the logistics and production of anti-infective drugs to third-party contractors. By analyzing the fundamental TTM net income per share metric, an investor can see the real efficiency of this strategy. This metric calculates the total net income for the year divided by the total number of shares, demonstrating the actual cash return per share of ownership. Steady growth in this indicator confirms the business model's resilience to market volatility.